Tyche Industries FY26 Profit Down 44% to ₹6.94 Cr, Recommends ₹3.50 Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Tyche Industries FY26 Profit Down 44% to ₹6.94 Cr, Recommends ₹3.50 Dividend
Overview

Tyche Industries reported a 44% drop in net profit for FY26 to ₹6.94 crore on an 18% revenue decline. Despite this, the company recommended a final dividend of ₹3.50 per share, with an unmodified auditor opinion.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Tyche Industries FY26 Results: Profit Declines 44%, Dividend Declared

Net Profit After Tax: ₹6.94 crore (FY26) vs ₹12.41 crore (FY25)
Revenue from Operations: ₹53.63 crore (FY26) vs ₹65.47 crore (FY25)

Reader Takeaway: Profitability and revenue contracted; auditor gives clean chit, dividend proposed.

What just happened

Tyche Industries Limited announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a significant contraction in its financial performance. Revenue from operations decreased by 18.08% to ₹53.63 crore compared to ₹65.47 crore in the previous fiscal year. Net profit after tax saw a steeper decline of 44.08%, falling to ₹6.94 crore from ₹12.41 crore in FY 2025. Basic earnings per share (EPS) also dropped by 45.04% to ₹6.70 from ₹12.19.

Why this matters

The substantial decrease in both revenue and net profit indicates a challenging operating environment for Tyche Industries during FY26. Investors will be concerned about the company's ability to sustain profitability and growth. However, the Board has recommended a final dividend of ₹3.50 per share (35%), suggesting a commitment to shareholder returns even amidst the downturn. The unmodified auditor opinion provides assurance on the financial reporting.

The backstory

Tyche Industries operates exclusively in the Active Pharmaceutical Ingredients (APIs) segment. Export sales formed a significant portion of its revenue, amounting to ₹48.41 crore in FY26. The previous fiscal year (FY25) had shown stronger performance.

What changes now

Investors will need to closely monitor the company's strategies to address the revenue and profit decline. The upcoming Annual General Meeting will be key for shareholder approval of the proposed dividend. Future guidance from the management on reversing the current trends will be critical.

Risks to watch

The primary risk is the continuation of the declining revenue and profit trend. Factors impacting the API segment, such as competition, regulatory changes, or demand fluctuations, could pose further challenges.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

  • Revenue FY26: ₹53.63 crore (down 18.08% YoY)
  • Net Profit FY26: ₹6.94 crore (down 44.08% YoY)
  • EPS FY26: ₹6.70 (down 45.04% YoY)
  • Dividend: ₹3.50 per share recommended for FY26

What to track next

Investors should track the company's quarterly results for signs of a turnaround, management commentary on future strategies, and any updates regarding the API market dynamics.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.